{
 "ok": true,
 "cik": "1842939",
 "ticker": "XAGE",
 "name": "Longevity Health Holdings, Inc.",
 "filings": [
  {
   "form": "8-K",
   "filed": "2026-09-08",
   "items": [
    "8.01 Other Events",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1842939/000143774926029755/0001437749-26-029755-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-09-04",
   "items": [
    "1.01 Entry into a Material Definitive Agreement",
    "2.03 Creation of a Direct Financial Obligation",
    "3.02 Unregistered Sales of Equity Securities",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1842939/000143774926029714/0001437749-26-029714-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-17",
   "items": [
    "8.01 Other Events",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1842939/000143774926028120/0001437749-26-028120-index.htm"
  },
  {
   "form": "10-Q",
   "filed": "2026-08-14",
   "items": [],
   "url": "https://www.sec.gov/Archives/edgar/data/1842939/000143774926028043/0001437749-26-028043-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-14",
   "items": [
    "1.01 Entry into a Material Definitive Agreement",
    "1.02 Termination of a Material Definitive Agreement",
    "2.03 Creation of a Direct Financial Obligation",
    "3.02 Unregistered Sales of Equity Securities",
    "5.02 Departure or Election of Directors; Appointment of Officers",
    "8.01 Other Events",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1842939/000143774926028011/0001437749-26-028011-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-06-04",
   "items": [
    "5.02 Departure or Election of Directors; Appointment of Officers"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1842939/000119312526257520/0001193125-26-257520-index.htm"
  }
 ],
 "events12m": 8,
 "sources": {
  "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001842939.json",
  "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1842939"
 },
 "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.",
 "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.",
 "edgar": "🫧 Edgar looked up Longevity Health Holdings, Inc. ($XAGE). Last filing: 8-K (8.01 Other Events), 2026-09-08. 8 event filings (8-K) in the past twelve months.",
 "auditor": {
  "changes": [],
  "nonReliance": [],
  "restatedSince": null
 },
 "metrics": {
  "fiscalYearEnd": "2025-12-31",
  "revenue": 1912811,
  "revenueGrowth1y": 37.01444811002027,
  "revenueGrowthPerYear": null,
  "yearsOfData": 3,
  "operatingMargin": -3.715773800966222,
  "operatingMarginPrior": -99.33816924361064,
  "netMargin": -3.6100179264966585,
  "operatingCashFlow": -3329266,
  "capitalSpending": 14225,
  "freeCashFlow": -3343491,
  "researchAndDevelopment": 788888,
  "researchShareOfRevenue": 0.41242339154260405,
  "cash": 706740,
  "longTermDebt": null,
  "longTermDebtChange": null,
  "revenueHistory": [
   {
    "fiscalYearEnd": "2023-12-31",
    "revenue": 0
   },
   {
    "fiscalYearEnd": "2024-12-31",
    "revenue": 50318
   },
   {
    "fiscalYearEnd": "2025-12-31",
    "revenue": 1912811
   }
  ],
  "totalEquity": -5866873,
  "totalAssets": 2367027,
  "equityRatio": -2.4785830495385137,
  "returnOnEquity": null,
  "dividendsPaid": null,
  "payoutRatio": null,
  "dividendPerShare": null,
  "dividendYearsRising": null,
  "dividendCut": null,
  "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.",
  "range80": {
   "low": 53365138.16032119,
   "high": 95823108.14507599,
   "baseline": 72714454.50377598,
   "n": 749,
   "band": "b00"
  },
  "ifPaceHeld": {
   "low": 53365138.16032119,
   "high": 95823108.14507599
  }
 },
 "edgarette": "🔖 Exposure: revenue $1.9M (FY2025). Experience: revenue up 3701.4% on the year; operating margin -371.6%, up from -9933.8%. Soundness: equity -247.9% of assets (liabilities exceed assets). Credibility: 3 audited years, moderate weight. Range: 80% of past cases like this landed between $53.4M and $95.8M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (14 filers, $50M+ revenue, its industry group): operating margin -371.6% against a 4.2% median; growth 3701.4% against 0.8%.",
 "peers": {
  "sic": 2840,
  "sicDescription": "Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics",
  "calendarYear": 2025,
  "minRevenue": 50000000,
  "depth": 3,
  "group": "284",
  "growth": [
   0.0084,
   14
  ],
  "opMargin": [
   0.0422,
   14
  ],
  "equityRatio": [
   0.395,
   14
  ],
  "returnOnEquity": [
   0.0377,
   11
  ]
 },
 "summary": "Longevity Health Holdings (XAGE) grew revenue 3701% in FY2025 to $2 million, operating margin -372% against a 4.2% median for soap, detergents, cleang preparations, perfumes, cosmetics, equity -248% of assets. Every figure is from the company’s own annual report filed with the SEC.",
 "chart": "<figure class=\"cmp\"><figcaption>Longevity Health Holdings, Inc. against its own record and its peers</figcaption><svg viewBox=\"0 0 560 112\" width=\"100%\" role=\"img\" aria-label=\"Comparison chart\"><rect x=\"0\" y=\"0\" width=\"560\" height=\"112\" fill=\"none\"/><text x=\"0\" y=\"34\" font-size=\"11\" fill=\"#6f6450\">Operating margin</text><rect x=\"148\" y=\"25\" width=\"338\" height=\"10\" rx=\"5\" fill=\"#efe7d6\"/><line x1=\"260.66666666666663\" y1=\"21\" x2=\"260.66666666666663\" y2=\"39\" stroke=\"#cfc5ae\" stroke-width=\"1\"/><line x1=\"284.43933333333337\" y1=\"20\" x2=\"284.43933333333337\" y2=\"40\" stroke=\"#c9a84c\" stroke-width=\"2.5\"/><title>Peer median 4.2%</title><circle cx=\"148\" cy=\"30\" r=\"6\" fill=\"#0a2240\" stroke=\"#fff\" stroke-width=\"1.5\"/><text x=\"494\" y=\"34\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">-371.6%</text><text x=\"0\" y=\"60\" font-size=\"11\" fill=\"#6f6450\">Revenue, on the year</text><rect x=\"148\" y=\"51\" width=\"338\" height=\"10\" rx=\"5\" fill=\"#efe7d6\"/><line x1=\"292.8571428571429\" y1=\"47\" x2=\"292.8571428571429\" y2=\"65\" stroke=\"#cfc5ae\" stroke-width=\"1\"/><line x1=\"296.9131428571429\" y1=\"46\" x2=\"296.9131428571429\" y2=\"66\" stroke=\"#c9a84c\" stroke-width=\"2.5\"/><title>Peer median 0.8%</title><circle cx=\"486\" cy=\"56\" r=\"6\" fill=\"#0a2240\" stroke=\"#fff\" stroke-width=\"1.5\"/><text x=\"494\" y=\"60\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">3701.4%</text><text x=\"0\" y=\"86\" font-size=\"11\" fill=\"#6f6450\">Equity of assets</text><rect x=\"148\" y=\"77\" width=\"338\" height=\"10\" rx=\"5\" fill=\"#efe7d6\"/><line x1=\"281.51\" y1=\"72\" x2=\"281.51\" y2=\"92\" stroke=\"#c9a84c\" stroke-width=\"2.5\"/><title>Peer median 39.5%</title><circle cx=\"148\" cy=\"82\" r=\"6\" fill=\"#0a2240\" stroke=\"#fff\" stroke-width=\"1.5\"/><text x=\"494\" y=\"86\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">-247.9%</text><text x=\"0\" y=\"110\" font-size=\"10\" fill=\"#8b8375\">Gold tick: the median of 14–14 peers with $50M+ revenue in soap, detergents, cleang preparations, perfumes, cosmetics</text></svg></figure>",
 "chartHorizon": null,
 "backtest": {
  "tests": 0,
  "hits": 0,
  "rate": null,
  "method": "v3",
  "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample."
 },
 "registry": {
  "logged": "2026-09-20T15:21:40.595Z",
  "hash": "445a906bf5db37cf",
  "status": "open"
 },
 "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.",
 "schema": "pops4.edgarette.card/1",
 "card": {
  "summary": "Longevity Health Holdings (XAGE) grew revenue 3701% in FY2025 to $2 million, operating margin -372% against a 4.2% median for soap, detergents, cleang preparations, perfumes, cosmetics, equity -248% of assets. Every figure is from the company’s own annual report filed with the SEC.",
  "exposure": {
   "fiscalYearEnd": "2025-12-31",
   "revenue": 1912811,
   "totalDebt": null,
   "cash": 706740
  },
  "experience": {
   "revenueGrowth1y": 37.01444811002027,
   "revenueGrowthPerYear": null,
   "operatingMargin": -3.715773800966222,
   "operatingMarginPrior": -99.33816924361064,
   "netMargin": -3.6100179264966585,
   "freeCashFlow": -3343491
  },
  "soundness": {
   "equityRatio": -2.4785830495385137,
   "returnOnEquity": null,
   "payoutRatio": null,
   "dividendPerShare": null,
   "dividendYearsRising": null,
   "dividendCut": null,
   "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown."
  },
  "peers": {
   "sic": 2840,
   "sicDescription": "Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics",
   "calendarYear": 2025,
   "minRevenue": 50000000,
   "depth": 3,
   "group": "284",
   "growth": [
    0.0084,
    14
   ],
   "opMargin": [
    0.0422,
    14
   ],
   "equityRatio": [
    0.395,
    14
   ],
   "returnOnEquity": [
    0.0377,
    11
   ]
  },
  "credibility": {
   "auditedYears": 3,
   "weight": "moderate",
   "standard": "ASOP No. 25",
   "nonReliance": null,
   "auditorChange": null
  },
  "range": {
   "low": 53365138.16032119,
   "high": 95823108.14507599,
   "baseline": 72714454.50377598,
   "coverage": 0.8,
   "method": "v3",
   "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out",
   "calibratedOn": {
    "companyYears": 749,
    "sizeBand": "b00"
   },
   "kind": "a calibrated range, not a forecast; no view on the share price",
   "track": {
    "backtest": {
     "tests": 0,
     "hits": 0,
     "rate": null,
     "method": "v3",
     "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample."
    },
    "registry": {
     "logged": "2026-09-20T15:21:40.595Z",
     "hash": "445a906bf5db37cf",
     "status": "open"
    },
    "scorecard": "https://www.pops4.com/boards/scorecard"
   }
  },
  "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.",
  "sources": {
   "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001842939.json",
   "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1842939"
  }
 },
 "definitions": {
  "operatingMargin": "Operating income divided by revenue.",
  "netMargin": "Net income divided by revenue.",
  "freeCashFlow": "Cash from operations minus spending on property and equipment.",
  "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.",
  "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.",
  "returnOnEquity": "Net income for the year against shareholders equity at year end.",
  "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.",
  "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.",
  "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.",
  "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.",
  "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.",
  "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so."
 }
}